Business · 12/03/2021Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of Five Bacitracin ANDAs
Summary
The FDA has withdrawn approval of five abbreviated new drug applications for Bacitracin for Injection from Akorn, Mylan, Pfizer, X-GEN, and Fresenius, following requests from the applicants to waive a hearing.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →
Related companies